ロード中...
ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
Although imatinib mesylate (IM) has transformed the treatment of gastrointestinal stromal tumors (GIST), many patients experience primary/secondary drug resistance. In a previous study, we identified a gene signature, consisting mainly of Kruppel-associated box (KRAB) domain containing zinc finger (...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3556080/ https://ncbi.nlm.nih.gov/pubmed/23372733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0054477 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|